Literature DB >> 11920336

Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies.

Gianna Mazzucco1, Tullio Bertani, Mirella Fortunato, Monica Bernardi, Monica Leutner, Renzo Boldorini, Guido Monga.   

Abstract

The frequency of various types of renal changes in patients with type 2 diabetes is not clearly defined in the literature. Reported discrepancies likely are caused by ethnic and geographic factors. However, policies used in nephrological centers for the selection of patients to undergo renal biopsy also may have an influence. The present study reports 393 renal biopsies in patients with type 2 diabetes performed in a group of centers in northwestern Italy using different (restricted [CRPs] or unrestricted [CUP]) biopsy policies. On the basis of light microscopic, immunofluorescence, and ultrastructural findings, cases were subdivided into three classes characterized by the presence of diabetic glomerulosclerosis (class 1), prevailing vascular (arterioarteriolosclerotic) and ischemic glomerular changes (class 2), other glomerulonephritides superimposed on diabetic glomerulosclerosis (class 3a), or glomerulonephritides without the presence of diabetic glomerulosclerosis (class 3b). Although no significant differences were found for class 2 (detected in 15% and 16% of patients from CRPs and the CUP, respectively), the frequency of the other two classes was strongly biased by the biopsy policy. Class 1 was found in 29% and 51% of cases, and class 3 in 57% and 33% of cases from CRPs and the CUP, respectively. Moreover, class 3a was more common (67%) in the CUP, and class 3b (78%) in CRPs. Our findings may explain conflicting data from the literature and the influence that type of adopted biopsy policy may have on an epidemiological evaluation. This study helps clarify the frequency of renal changes in patients with type 2 diabetes and suggests more extensive use of renal biopsy to obtain reliable prognostic indications and plan a rational therapeutic approach. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11920336     DOI: 10.1053/ajkd.2002.31988

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  56 in total

Review 1.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

Review 2.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 3.  Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients.

Authors:  Michael Mauer; Maria Luiza Caramori; Paola Fioretto; Behzad Najafian
Journal:  Nephrol Dial Transplant       Date:  2014-09-01       Impact factor: 5.992

4.  The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy.

Authors:  Hongfei Ji; Lina Wu; Xiaokun Ma; Xiaojun Ma; Guijun Qin
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

Review 5.  Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

Authors:  Helen C Looker; Michael Mauer; Robert G Nelson
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

6.  Acute kidney injury in a diabetic haemophiliac: one step at a time.

Authors:  Mohammed Mahdi Althaf; Maged Hassan Hussein; Mohamed Said Abdelsalam; Sadiq Mohammed Amer
Journal:  BMJ Case Rep       Date:  2014-05-08

7.  Non-diabetic glomerular lesions in diabetic kidney disease: clinical predictors and outcome in an Eastern European cohort.

Authors:  Otilia Popa; Gabriel Stefan; Cristina Capusa; Eugen Mandache; Simona Stancu; Nicoleta Petre; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2020-10-31       Impact factor: 2.370

Review 8.  Temporal profile of diabetic nephropathy pathologic changes.

Authors:  Cecilia Ponchiardi; Michael Mauer; Behzad Najafian
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

9.  The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.

Authors:  Nora Franceschini; V Saroja Voruganti; Karin Haack; Laura Almasy; Sandy Laston; Harald H H Goring; Jason G Umans; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Jean W MacCluer; Barbara V Howard; Kari E North; Shelley A Cole
Journal:  Hum Genet       Date:  2010-03       Impact factor: 4.132

10.  Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes.

Authors:  Elizabeth A C Sellers; Tom D Blydt-Hansen; Heather J Dean; Ian W Gibson; Patricia E Birk; Malcolm Ogborn
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.